Quick Overview
A 2014 US clinical trial tested peroneal-nerve functional electrical stimulation, a targeted form of EMS, against an ankle-foot brace in 495 people with chronic stroke and foot drop.
Teams at 30 centres measured gait speed, six-minute distance, obstacle walking, balance, and quality-of-life scores for six months.
Both groups gained about 0.19 m/s, a roughly 40 percent rise in walking speed. FES matched the brace on primary outcomes and improved some functional tasks within its own group.
Published in Neurorehabilitation and Neural Repair by Cleveland Clinic and other hospitals, the data suggest targeted EMS can aid walking after stroke.
The full post has the exact numbers, safety findings, and limits.
We always provide direct links to the original research at the end of every article so you can review the evidence yourself.
ย
Stroke Survivors Walked Faster After Targeted Leg Stimulation, Large US Trial Finds
ย

ย
Foot drop can make every step feel uncertain after a stroke.
Many people drag the affected foot. Walking slows. Falls become a real worry.
ย

ย
A large clinical trial asked a simple question. Could functional electrical stimulation, a targeted form of EMS, help as much as a walking brace?
The answer from this study was encouraging.
Who ran the research
This was not a small lab note.
It was a randomised controlled trial. It ran at 30 rehabilitation centres across the United States.
ย

ย
The paper was published in 2014 in Neurorehabilitation and Neural Repair. That is a peer-reviewed scientific journal from SAGE.
Lead author Francois Bethoux, MD, worked at Cleveland Clinic. Other investigators came from university hospitals, Veterans Affairs centres, and specialist rehab institutes.
The trial is listed as NCT01087957. That public record helps readers check the design.
These details matter. They show the write-up below comes from published science, not guesswork.
Who took part
ย

ย
Researchers screened 761 people. They enrolled 495 adults who were eligible for Medicare.
Everyone was at least six months after stroke. On average, they were about 6.9 years after onset.
All had foot drop. At the start, they walked slower than 0.8 metres per second on a 10-metre test.
Three hundred and ninety-nine people finished six months. That is a large completed group for this kind of walking study.
What people used
ย

ย
One group used the WalkAideย FES system. It is a cuff on the lower leg.
Surface electrodes stimulate the peroneal nerve. That timed pulse lifts the foot in the swing phase of walking.
The other group used an ankle-foot orthosis, the usual brace for foot drop.
People followed a two-week wearing plan. Then they were asked to use the device for walking through the day.
This trial tested a specific walking device. It did not test every consumer EMS belt on the market.
What the team measured
ย

ย
They tracked walking speed on the 10-metre walk test.
They also used a Stroke Impact Scale composite. It combined mobility, daily activities, and social participation.
Safety was a primary endpoint. The team counted device-related serious adverse events.
Secondary tests included the 6-minute walk, GaitRite walking quality, the modified Emory functional walking tasks, Berg balance, Timed Up and Go, and quality-of-life scales.
In plain terms, they measured speed, endurance, real-world walking tasks, balance, and how life felt.
The main walking result
Both groups walked faster after six months.
In the FES group, mean speed rose from 0.449 m/s to 0.635 m/s. That was a gain of 0.186 m/s.
In the brace group, speed rose from 0.487 m/s to 0.682 m/s. That was a gain of 0.195 m/s.
Those gains sat above commonly cited meaningful change levels for gait after stroke.
ย

ย
The FES group improved by about 41 percent from its starting speed. The brace group improved by about 40 percent.
The between-group difference was tiny: 0.009 m/s. The 95 percent confidence interval ran from โ0.04 to 0.06.
Researchers set a non-inferiority margin of 0.2 m/s. FES met that test. It was not worse than the brace on speed.
Average speeds also moved from โmost-limited community walkingโ toward โleast-limited community walkingโ on Perryโs categories.
That shift is one reason the speed change matters in daily life.
Quality of life and daily function
ย

ย
The FES groupโs composite Stroke Impact Scale score rose from 170.0 to 175.0. That was a 5-point gain.
The brace group rose from 168.8 to 172.7.
FES was again non-inferior on this composite. The margin allowed was 15 points.
The composite change was statistically significant inside the FES group. It did not reach the larger change some papers call clinically important.
So the signal was real, but modest on that particular score.
Functional walking tasks
ย
Here the FES group showed several within-group gains.
Total modified Emory walking time fell from 594.0 seconds to 498.0 seconds. That was a 96-second improvement.
ย

ย
Floor walking time fell by 12.0 seconds. Obstacle-course time fell by 42.6 seconds.
GaitRite functional ambulation profile rose from 59.8 to 65.6.
Berg balance rose by 2.6 points in the FES group.
After a strict Bonferroni correction, those within-group changes reached significance for several FES measures. Between-group differences did not.
The study still treated FES as equivalent overall, not proven superior.
Safety findings
ย

ย
Device-related serious events were rare.
None were reported in the FES group. Two were reported in the brace group.
Falls were common in both groups, as they often are after stroke. They were not clearly different by device.
Skin irritation was reported more often with FES than with the brace. That is a practical point for anyone considering stimulation.
Overall, the authors called both options low risk for serious device harm in this trial.
What this does โ and does not โ prove
ย

ย
This paper supports a bright, careful claim.
In people with chronic stroke and foot drop, six months of peroneal-nerve FES matched a standard brace on walking speed and on the chosen quality-of-life composite.
Both groups made meaningful speed gains. That is the strongest good-news finding.
Some extra improvements showed up inside the FES group on obstacle walking, floor walking, gait quality, and balance scores.
The authors said FES should be considered a viable alternative to bracing for the right patient.
They also said not every person with foot drop can use it. The nerve must respond. The person must tolerate the stimulus.
The trial did not show that โmore stimulation is always better.โ People used a prescribed walking device, not unlimited extra sessions.
It also did not test abdominal EMS, fitness belts, or do-it-yourself programs.
Different devices stimulate different nerves and muscles. Results from this walking system should not be copied onto every stimulator.
Why the source is worth reading
ย

ย
The work came from established hospitals and research centres.
It used random assignment. It followed people for six months. It analysed hundreds of participants.
It was published in a specialist rehabilitation journal, not an advert.
That is why a blog can discuss it as science. The paper is public. The methods are described. The numbers are in the tables.
A practical note
This summary is education about one published trial. It is not a treatment prescription.
Stroke care is individual. Devices used for walking problems may be regulated as medical products.
If you or someone you love has foot drop after stroke, speak with a doctor, neurologist, or physiotherapist. Ask whether FES or a brace is appropriate. Ask which device, if any, is suitable.
Do not start electrical stimulation after stroke on the basis of a blog post alone.
ย

ย
The hopeful takeaway is still clear. In this large US trial, targeted electrical stimulation during walking helped many people move faster. It did so on par with the usual brace. For the right person, that is a useful option to discuss with a clinician.
Like this Research Digest? ๐
Share it with your friends ๐ฌ๐ https://bit.ly/4r6MtrL
About Our Health Research Digest
We bring you the latest and most important health research papers โ simplified and easy to understand.
Each study is broken down into clear, concise summaries and engaging podcasts, with direct links to the original research so you can explore further whenever you like.
We also create content based on your requests. If youโre curious about a specific health topic or would like us to find relevant studies, simplify the findings, and turn them into a podcast, just let us know.
Donโt hesitate to reach out โ weโre here to help make health research accessible and useful for you. Contact us anytime.
Moreย ย EMSย ย Research Scientists Are Studying
1. Canย EMSย ย reduce fat?ย
2. Can ย EMSย increaseย calorie burn while sitting?
3. Can ย EMSย support muscle toning and muscle gains?
4. Can ย EMSย ย improve athleticย training?
5. Can ย EMSย ย play a role in muscle loss & frailty?
6. Can ย EMSย reduce pain?ย
7.ย ย EMSย ย vs TENS: What are the differences?
8. Canย EMS ย play a role after stroke?
Research Summary
| Topic | What the study reported |
|---|---|
| Full paper | Bethoux et al., โThe Effects of Peroneal Nerve Functional Electrical Stimulation Versus Ankle-Foot Orthosis in Patients With Chronic Stroke: A Randomized Controlled Trial,โ Neurorehabilitation and Neural Repair, 2014;28(7):688โ697. |
| Original study links | SAGE journal page ยท PubMed 24526708 ยท DOI 10.1177/1545968314521007 |
| Trial registry | ClinicalTrials.gov NCT01087957 (INSTRIDE). |
| Publisher | SAGE; peer-reviewed specialist journal in neurorehabilitation. |
| Research team | Lead author Francois Bethoux, MD, Cleveland Clinic, with investigators from US university hospitals, VA centres, and rehabilitation institutes. |
| Design | Unblinded, parallel-group randomised controlled trial at 30 US centres. Primary tests used non-inferiority; analysis was intention-to-treat with multiple imputation. |
| Sample | 761 screened, 495 enrolled, 399 completed six months (187 FES, 212 AFO). |
| Participants | Medicare-eligible adults at least 6 months after stroke, with foot drop and screening 10-metre speed no faster than 0.8 m/s. Mean time since stroke about 6.9 years. |
| Devices tested | WalkAide peroneal-nerve FES versus a custom or standard-of-care ankle-foot orthosis, used for daily walking after a 2-week wearing schedule. |
| Primary endpoints | 10-Metre Walk Test, SIS composite (Mobility + ADL/IADL + Social Participation), and device-related serious adverse events. |
| Other endpoints | 6-minute walk, GaitRite FAP, modified Emory walking tasks, Berg Balance Scale, Timed Up and Go, individual SIS domains, and Stroke-Specific Quality of Life. |
| Gait-speed result | FES rose from 0.449 to 0.635 m/s (+0.186). AFO rose from 0.487 to 0.682 m/s (+0.195). Both groups improved. FES met non-inferiority versus a โ0.2 m/s margin. |
| Quality-of-life composite | FES SIS composite rose 5.0 points (170.0 to 175.0). AFO rose 3.9 points. FES met non-inferiority versus a โ15-point margin. |
| Functional walking and balance | Within the FES group: mEFAP total โ96.0 s, floor time โ12.0 s, obstacle course โ42.6 s, FAP +5.8, Berg balance +2.6. Between-group differences were not significant after correction. |
| Safety | Device-related serious events: none in FES, two in AFO. Falls were common in both groups. Skin irritation was reported more often with FES. |
| Authorsโ conclusion | FES was equivalent to AFO on the primary endpoints and was described as a viable alternative for suitable people with foot drop after chronic stroke. |
| Limits | Assessments were unblinded; about 20% exited early; device wear was not systematically tracked; follow-up was 6 months; FES requires an adequate dorsiflexion response. This trial tested a walking FES system, not every EMS product. |
| Funding and disclosures | Sponsored by Innovative Neurotronics. A co-author was a company employee; the lead author disclosed consulting linked to the trial. |
Related Posts Worth Reading
-
2026 Study coauthored by John Hopskin University School of Medicine , Published in Stroke / American Heart Association journal article
ย
-
2015 Study - Published by BioMed Research International
ย
-
A 2017 systematic review in Systematic Reviews, published by BioMed Central
ย
-
2025 study published in Frontiers in Neurology by Frontiers Media, Switzerland.
-
2018 study published in Archives of Physical Medicine and Rehabilitation by Elsevier, Netherlands.
ย
-
2024 study published in Archives of Physical Medicine and Rehabilitation by Elsevier, Netherlands.
ย
-
2024 study published in Archives of Physical Medicine and Rehabilitation by Elsevier, Netherlands.
-
2025 study published in Progress in Rehabilitation Medicine by the Japanese Association of Rehabilitation Medicine, Japan.
ย
-
2014 study published in Journal of Physiotherapy by Elsevier, Netherlands.
-
2013 Study Published by Stroke Journal, American Heart Association, United States
ย
-
2006 study published in the Australian Journal of Physiotherapy by Elsevier, Netherlands.
ย
-
2020 Study Published by Frontiers in Neuroscienceย
ย
-
2022 Study Published by Annals of Geriatric Medicine and Research
ย
ย
ย
-
2023 Studyย Published in theย International Journal of Physiotherapy
ย
-
2024 Study Published by The Rehabilitation Journal
ย
-
2022 Study Published in International Journal of Environmental Research and Public Health,
ย
-
2021 Study Published by Journal of International Medical Research
ย
-
2025 study published by the Japanese Association of Rehabilitation Medicine.
ย
-
2025 Study published by Cochrane Database of Systematic Reviews
ย
-
ย 2014 Study Published in Neurorehabilitation and Neural Repair.ย
ย
ย
-
Study Conducted onย 93 Stroke People ย Published on Neurorehabilitation and Neural Repairย
ย
-
Study conducted on 197 Stroke people , published in Stroke Journal, American Heart Association, United States
ย
-
2016 Study Conducted on 815 Stroke Survivors , Published by Journal of Rehabilitation Medicine
ย
ย
ย
ย
-
2025 Review Conducted on 933 People, Published by Disability and Rehabilitation, Taylor & Francis
ย
-
2017 Study, Published in Systematic Reviews, BioMed Central
ย
-
University of Glasgow Study Published in the American Heart Association journalย Stroke
ย
-
Study Conducted on 120 People After Stroke, Published in American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation
-
2023 Study Published in Pain and Therapy (Adis / Springer Nature)
-
2020 Study Published in ๐ญ๐๐๐๐๐๐๐๐ ๐๐ ๐ต๐๐๐๐๐๐๐๐๐๐๐.
-
2016 Study Published in The Society of Physical Therapy Science, published by IPEC Inc., Japan
ย
ย
ย
Disclaimer
This article is published forย general information and educational purposes only. It does not constitute medical advice, health advice, diagnosis, or treatment of any kind.
All content on this website, including any studies, research, or information mentioned, is provided for informational purposes only and does not imply or guarantee any specific health outcomes.
We are not affiliated with, endorsed by, or connected in any way to any researchers, universities, research centres, journals, or institutions referenced in any article. No reference to any study, researcher, or publication should be interpreted as an endorsement or recommendation of any products sold or featured on this website.
Our products (and any products featured or linked in this article) are not intended to diagnose, treat, cure, prevent, or manage any disease or medical condition. Individual results may vary significantly. No guarantees or warranties are made regarding effectiveness, safety, or specific outcomes.
Always consult a qualified healthcare professional before using any product mentioned on this website or making any changes to your health routine, especially if you have a pre-existing medical condition, are pregnant, breastfeeding, have a pacemaker, or are taking medication.
To the fullest extent permitted by law, ORIEMS FIT, its directors, employees, authors, affiliates, and agents disclaim all liability for any loss, damage, cost, expense, or injury (whether direct, indirect, consequential, special, or incidental) arising from the use of, or reliance upon, any information in this article or from the purchase or use of any products featured or sold on this website.
ยฉ [ORIEMS FIT] โ All Rights Reserved.































